Posted by Michael Wonder on 12 Mar 2020
PHARMAC funds new medicine (mepolizumab) for severe asthma
12 March 2020 - Around 500 New Zealanders who have severe asthma will have access to a new medicine, mepolizumab, from next month.
Severe asthma sufferers who use mepolizumab are less likely to end up in hospital and less likely to experience their symptoms getting worse during an asthma attack.
One of those severe asthma sufferers is Alex, who has been taking steroids for over thirty years. Four weeks ago, she had her first injection of mepolizumab.
